Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

[Efficacity of rituximab in hemolytic anemia with cold autoantibodies case].

Sekkach Y, Hammi S, Elqatni M, Fatihi J, Elomri N, Mekouar F, Badaoui M, Jira M, Smaali J, El Khattabi A, Amezyane T, Abouzahir A, Ghafir D.

Ann Pharm Fr. 2011 Jul;69(4):205-8. doi: 10.1016/j.pharma.2011.06.002. Epub 2011 Jul 19. French.

PMID:
21840439
2.
3.

B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.

Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, de Vita S, Regazzi M, Baccarani M, Fanin R.

Haematologica. 2002 Feb;87(2):189-95. Erratum in: Haematologica 2002 Mar;87(3):336.

4.

High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease.

Berentsen S, Randen U, Vågan AM, Hjorth-Hansen H, Vik A, Dalgaard J, Jacobsen EM, Thoresen AS, Beiske K, Tjønnfjord GE.

Blood. 2010 Oct 28;116(17):3180-4. doi: 10.1182/blood-2010-06-288647. Epub 2010 Jul 15.

5.

[Cold agglutinin disease -  no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].

Adam Z, Pejchalová A, Chlupová G, Ríhová L, Pour L, Krejčí M, Cervinek L, Král Z, Mayer J.

Vnitr Lek. 2013 Sep;59(9):828-40. Review. Czech.

PMID:
24073955
6.

[Rituximab in cold agglutinin disease].

Camou F, Viallard JF, Pellegrin JL.

Rev Med Interne. 2003 Aug;24(8):501-4. French.

PMID:
12888170
7.

Remission of severe cold agglutinin disease after Rituximab therapy.

Layios N, Van Den Neste E, Jost E, Deneys V, Scheiff JM, Ferrant A.

Leukemia. 2001 Jan;15(1):187-8. No abstract available.

PMID:
11243390
8.

[Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].

Ono K, Sato T, Iyama S, Tatekoshi A, Hashimoto A, Kamihara Y, Horiguchi H, Kikuchi S, Takada K, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Rinsho Ketsueki. 2013 Nov;54(11):2053-5. Japanese.

PMID:
24305538
9.

Successful rituximab therapy in the treatment of refractory cold haemagglutinin disease with long-term disease control.

Khalafallah A, Vos LJ, Beamish M, Rooney K.

Intern Med J. 2010 May;40(5):387-9. doi: 10.1111/j.1445-5994.2010.02173.x. No abstract available.

PMID:
20575998
11.

Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases.

Zaja F, Vianelli N, Sperotto A, Patriarca F, Tani M, Marin L, Tiribelli M, Candoni A, Baccarani M, Fanin R.

Leuk Lymphoma. 2003 Nov;44(11):1951-5.

PMID:
14738149
12.

Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.

Berentsen S, Tjønnfjord GE.

Blood Rev. 2012 May;26(3):107-15. doi: 10.1016/j.blre.2012.01.002. Epub 2012 Feb 12. Review.

PMID:
22330255
13.

Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report.

Gupta S, Szerszen A, Nakhl F, Varma S, Gottesman A, Forte F, Dhar M.

J Med Case Rep. 2011 Apr 19;5:156. doi: 10.1186/1752-1947-5-156.

14.

Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy.

Mori A, Tamaru J, Sumi H, Kondo H.

Eur J Haematol. 2002 Apr;68(4):243-6.

PMID:
12071942
15.

Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder.

Jourdan E, Topart D, Richard B, Jourdan J, Sotto A.

Leuk Lymphoma. 2003 May;44(5):889-90.

PMID:
12802933
16.

Plasma exchange and rituximab treatment for lenalidomide-associated cold agglutinin disease.

Brauer DL, Edelman B, Rapoport AP, Hess JR, Akpek G.

Transfusion. 2012 Nov;52(11):2432-5. doi: 10.1111/j.1537-2995.2012.03608.x. Epub 2012 Mar 21.

PMID:
22435421
17.

Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.

Gueli A, Gottardi D, Hu H, Ricca I, De Crescenzo A, Tarella C.

Blood Transfus. 2013 Apr;11(2):311-4. doi: 10.2450/2012.0166-12. Epub 2013 Jan 22. No abstract available.

18.

[Delayed response to rituximab of cold agglutinin haemolytic disease].

Calvo-Villas JM, Cuesta Tovar J, Carreter de Granda E, Sicilia Guillén F.

An Med Interna. 2006 May;23(5):224-8. Spanish.

PMID:
16817700
19.

[The long-term efficacy and safety of rituximab combined with cyclophosphamide in treatment of seven patients with refractory and recurrent autoimmune hemolytic anemia].

Liu H, Xing LM, Wang HQ, Wu YH, Qu W, Liang Y, Wang GJ, Song J, Wang XM, Guan J, Li LJ, Fu R, Shao ZH.

Zhonghua Nei Ke Za Zhi. 2012 Jun;51(6):456-9. Chinese.

PMID:
22943757
20.

Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström's macroglobulinemia.

Hattori N, Ishii N, Ariizumi H, Adachi D, Matsuda I, Nakamaki T, Tomoyasu S.

Ann Hematol. 2010 Jan;89(1):103-4. doi: 10.1007/s00277-009-0773-z. Epub 2009 Jun 10. No abstract available.

PMID:
19513714

Supplemental Content

Support Center